Knights of Columbus Asset Advisors’s NewAmsterdam Pharma NAMS Stock Holding History

Knights of Columbus Asset Advisors’s Portfolio NAMS Stock Details NAMS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.48M	Buy	43,800 +7,610	+21%	+$251K	0.07%	248
2026 Q1	$1.16M	Buy	36,190 +3,707	+11%	+$121K	0.07%	251
2025 Q4	$1.14M	Sell	32,483 -1,127	-3%	-$41K	0.06%	249
2025 Q3	$956K	Buy	33,610 +777	+2%	+$18.6K	0.05%	266
2025 Q2	$595K	Buy	+32,833	New	+$599K	0.04%	273

Other funds holding NAMS

FLSM

Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

FIS

FCPM III Services Naarden, Netherlands $750M AUM 127.27% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return

Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return

DFO

Duquesne Family Office New York $5.21B AUM 87.01% 1-Year Est. Return

Knights of Columbus Asset Advisors's NAMS Position: Q2 2026 in Review

Knights of Columbus Asset Advisors increased its NewAmsterdam Pharma (NAMS) stake by 21% in Q2 2026, buying an estimated $251K and bringing the position to 43,800 shares worth $1.48M. The position accounts for 0.07% of the portfolio, ranked #248.

Knights of Columbus Asset Advisors first reported a position in NAMS in Q2 2025 and has held it in 5 quarters since. 194 funds tracked by Wall St. Rank hold NAMS as of Q2 2026.

Knights of Columbus Asset Advisors held 43,800 shares of NewAmsterdam Pharma worth $1.48M as of Q2 2026.
Knights of Columbus Asset Advisors bought 7,610 NewAmsterdam Pharma shares in Q2 2026, an estimated $251K.
NewAmsterdam Pharma made up 0.07% of Knights of Columbus Asset Advisors's portfolio in Q2 2026, its #248 holding.
Knights of Columbus Asset Advisors first reported a position in NewAmsterdam Pharma in Q2 2025 and has held it in 5 quarters since.
194 funds tracked by Wall St. Rank held NewAmsterdam Pharma as of Q2 2026.

Based on Knights of Columbus Asset Advisors's 13F filing for Q2 2026, filed 31 Jul 2026.